Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease.
about
Review article: new treatments in non-alcoholic fatty liver disease.The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Effects of resveratrol, exercises and their combination on gene expression and apoptosis in the liver of elderly rats with nonalcoholic fatty liver
P2860
Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Sevelamer Improves Steatohepat ...... alcoholic Fatty Liver Disease.
@en
Sevelamer Improves Steatohepat ...... alcoholic Fatty Liver Disease.
@nl
type
label
Sevelamer Improves Steatohepat ...... alcoholic Fatty Liver Disease.
@en
Sevelamer Improves Steatohepat ...... alcoholic Fatty Liver Disease.
@nl
prefLabel
Sevelamer Improves Steatohepat ...... alcoholic Fatty Liver Disease.
@en
Sevelamer Improves Steatohepat ...... alcoholic Fatty Liver Disease.
@nl
P2093
P2860
P356
P1476
Sevelamer Improves Steatohepat ...... -alcoholic Fatty Liver Disease
@en
P2093
Cara Porsche
David J Orlicky
Hugo R Rosen
Moshe Levi
Rachel H McMahan
Xiaoxin X Wang
Yuhuan Luo
P2860
P304
23058-23067
P356
10.1074/JBC.M116.731042
P407
P577
2016-09-07T00:00:00Z